About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 San Antonio Breast Cancer Symposium
2019 ASH Annual Meeting & Exposition
2019 Lynn Sage Breast Cancer Symposium
2019 Chemotherapy Foundation Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Syed Ali Abutalib, MD, and Navneet Majhail, MD, MS"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
T-DXd in Patients With Pretreated HER2-Positive Metastatic Breast Cancer
Adding Tucatinib to Capecitabine/Trastuzumab Improved Survival for Patients With Advanced HER2-Positive Breast Cancer
Ribociclib/Letrozole vs Multiagent Chemotherapy in Patients With High-Risk Luminal B Breast Cancer
Long-Term Preventive Benefit With Anastrozole Among Postmenopausal Women at High Risk for Breast Cancer
Breast Cancer Incidence With Estrogen/Progestin vs Estrogen Alone in Postmenopausal Women
Most Read Stories
ASH 2019: Is Autologous Hematopoietic Stem Cell Transplant Safe and Effective for Patients Aged 70 or Older With Multiple Myeloma?
SABCS 2019: Postoperative S-1 Plus Endocrine Therapy for HR-Positive, HER2-Negative Breast Cancer
I Plan to Live Long Enough to Be Cured of Multiple Myeloma
SABCS 2019: Oral vs Intravenous Paclitaxel for Patients With Metastatic Breast Cancer
FDA Approves FoundationOne CDx as a Companion Diagnostic for Alpelisib/Fulvestrant Treatment in Breast Cancer
© 2019 HSP News Service, L.L.C.